TPI demalonylation at K56 decreases PPP flux in CDCP1+ CSCs and is indispensable for postchemotherapeutic recurrence. by WenChao Gao (7321640)

Validation of primary screen hits reveals compounds that recapitulate increased spheroid size (swell) or decreased MUC5AC in the lumen. by Pranjali Beri (14945400)

“…Compounds that appeared to cause toxicity were identified by observing a significant decrease in spheroid counts in the swell readout or a significant decrease in the total nuclear intensity of the MUC5AC ratio readout. …”

BA attenuated the decrease in the expression of ZO-1 and Occludin induced by LPS in Caco2 cells. by Luqiong Liu (11537092)

VPS34 inhibition decreases intracellular levels of cholesteryl-esters, blocks cholesterol uptake and enhances lysosomal degradation of LDLR. by Marek J. Kobylarz (9292599)

DDX5 and DDX17 decrease viral gene expression during KSHV lytic reactivation in iSLK.219 cells. by Praneet Kaur Sandhu (21156149)

Pairwise correlations of excitatory neurons in APP/PS1 mice are decreased in dCA1, but increased in vCA1. by Udaysankar Chockanathan (18510288)

MVEC microvessel formation is restricted in hydrogels exhibiting increased stiffness or decreased concentration of adhesive peptides. by Rebecca A. Scott (488956)

“…An unpaired student’s t-test detect statistical significance, *p<0.05 for 7.5 wt% hydrogels containing 3 mM RGD relative to either (<b>A, C-F</b>) 15wt% hydrogels containing 3 mM RGD or (<b>G, I-L</b>) 7.5wt% hydrogels containing 1 mM RGD.…”

GSK343 decreased viability and proliferation in human neuroblastoma PDX cells. by Laura V. Bownes (10276762)

“…Treatment with GSK343 resulted in significantly decreased migration. (D) After 24 hours of treatment with increasing concentrations of GSK343 (0, 5, 10 μM), COA3 and COA6 cells (4.0 × 10⁴) were plated in Transwell^® inserts and allowed to invade for 1 week through a Matrigel^™ layer. …”

Zebrafish TMEM33 decreases TBK1-mediated MITA phosphorylation. by Long-Feng Lu (6528632)

<i>Elsholtzia ciliata</i> extract (ECE) treatment decreases coronavirus-induced plaque formation. by Siyun Lee (17087351)

“…<b>(B)</b> ECE treatment decreases plaque formation in a dose-dependent manner. …”

rHSP60 decreases LPS-induced mononuclear cell proliferation. by Igor Emiliano L. Souza (18196495)

rhMG53 decreases membrane damage <i>in vitro</i>. by Brian J. Paleo (8694246)

DICER protein expression is significantly decreased in the absence of MOV10 and FMRP. by Monica C. Lannom (11772729)

Umbelliprenin treatment decreases the activity of the TCF reporter in gastric cancer cells. by Lijing Zhang (463702)

Nrf2 activation decreases PMN ROS production in response to zymosan. by Doumet Georges Helou (7255823)

Syndecan ectodomain fragments decrease endothelial resistance via rho kinase. by Melanie Jannaway (6703577)

“…(C) rhS4ED fragments significantly decreased TER (n = 8, p = 0.0002). (D) Fragments of non-glycosylated form of rhS4ED also generated significant decreases in TER (n = 5, p = 0.0011). …”

Dimethylethanolamine decreases epileptiform activity in acute human hippocampal slices in vitro by Larissa Kraus (6712265)

MET knockdown decreases EGFR activation and does not influence EGFR expression. by Karolin Ebert (7434713)

TREM1 inhibition decreases HIV mediated inflammatory cytokine production. by Jinhee Hyun (6900683)

<i>cd9b</i> MO caused a decrease in neuromasts deposited at 52 hpf. by Katherine S. Marsay (11772718)

“…B-G: Representative images of WISH of <i>claudin b</i> at 52 hpf of (b) uninjected embryos, (c) embryos with 0.5 μM Mismatch, (d) 0.1 μM <i>cd9b</i> MO1, (e) 0.1 μM <i>cd9b</i> i2e3 MO1, (f) 0.2 μM <i>cd9b</i> MO1, (g) 0.2 μM <i>cd9b</i> i2e3 MO. …”